Literature DB >> 16116177

Sphingosine 1-phosphate receptors regulate chemokine-driven transendothelial migration of lymph node but not splenic T cells.

Adam C Yopp1, Jordi C Ochando, Minwei Mao, Levi Ledgerwood, Yaozhong Ding, Jonathan S Bromberg.   

Abstract

Chemokines and chemokine receptors are required for T cell trafficking and migration. Recent evidence shows that sphingosine 1-phosphate (S1P) and S1PRs are also important for some aspects of T cell migration, but how these two important receptor-ligand systems are integrated and coregulated is not known. In this study, we have investigated CCL19-CCR7 and CXCL12-CXCR4-driven migration of both splenic and peripheral lymph node (PLN) nonactivated and naive T cells, and used both S1P and the S1PR ligand, FTY720, to probe these interactions. The results demonstrate that splenic T cell migration to CCL19 or CXCL12 is enhanced by, but does not require, S1PR stimulation. In contrast, PLN T cell migration to CXCL12, but not CCL19, requires both chemokine and S1PR stimulation, and the requirement for dual receptor stimulation is particularly important for steps involving transendothelial migration. The results also demonstrate that: 1) splenic and PLN nonactivated and naive T cells use different molecular migration mechanisms; 2) CCR7 and CXCR4 stimulation engage different migration mechanisms; and 3) S1P and FTY720 have distinct S1PR agonist and antagonist properties. The results have important implications for understanding naive T cell entry into and egress from peripheral lymphoid organs, and we present a model for how S1P and chemokine receptor signaling may be integrated within a T cell.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16116177     DOI: 10.4049/jimmunol.175.5.2913

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

2.  CXCR4 modulates contractility in adult cardiac myocytes.

Authors:  Robert T Pyo; Jinliang Sui; Ashwini Dhume; Julieta Palomeque; Burns C Blaxall; George Diaz; James Tunstead; Diomedes E Logothetis; Roger J Hajjar; Alison D Schecter
Journal:  J Mol Cell Cardiol       Date:  2006-09-28       Impact factor: 5.000

Review 3.  Geography and plumbing control the T cell response to infection.

Authors:  Kamal M Khanna; Leo Lefrançois
Journal:  Immunol Cell Biol       Date:  2008-04-08       Impact factor: 5.126

4.  The low down on sphingosine-1-phosphate lyase as a regulator of thymic egress.

Authors:  Julie D Saba
Journal:  J Immunol Sci       Date:  2017-12-06

5.  A sphingosine-1-phosphate receptor 1 agonist inhibits tertiary lymphoid tissue reactivation and hypersensitivity in the lung.

Authors:  C A Huppé; P Blais Lecours; A Lechasseur; D R Gendron; A M Lemay; E Y Bissonnette; M R Blanchet; C Duchaine; M C Morissette; H Rosen; D Marsolais
Journal:  Mucosal Immunol       Date:  2017-04-19       Impact factor: 7.313

6.  FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.

Authors:  Paolo Neviani; Ramasamy Santhanam; Joshua J Oaks; Anna M Eiring; Mario Notari; Bradley W Blaser; Shujun Liu; Rossana Trotta; Natarajan Muthusamy; Carlo Gambacorti-Passerini; Brian J Druker; Jorge Cortes; Guido Marcucci; Ching-Shih Chen; Nicole M Verrills; Denis C Roy; Michael A Caligiuri; Clara D Bloomfield; John C Byrd; Danilo Perrotti
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

Review 7.  The role of sphingosine-1-phosphate and its receptors in asthma.

Authors:  John J Ryan; Sarah Spiegel
Journal:  Drug News Perspect       Date:  2008-03

8.  Local not systemic modulation of dendritic cell S1P receptors in lung blunts virus-specific immune responses to influenza.

Authors:  David Marsolais; Bumsuk Hahm; Kurt H Edelmann; Kevin B Walsh; Miguel Guerrero; Yasuko Hatta; Yoshihiro Kawaoka; Edward Roberts; Michael B A Oldstone; Hugh Rosen
Journal:  Mol Pharmacol       Date:  2008-06-24       Impact factor: 4.436

Review 9.  [FTY720 (Fingolimod) as a new therapeutic option for multiple sclerosis].

Authors:  J Klatt; H-P Hartung; R Hohlfeld
Journal:  Nervenarzt       Date:  2007-10       Impact factor: 1.214

10.  Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures.

Authors:  Robert P Lisak; Joyce A Benjamins; Beverly Bealmear; Liljana Nedelkoska; Diane Studzinski; Ernest Retland; Bin Yao; Susan Land
Journal:  J Neuroinflammation       Date:  2009-01-21       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.